ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business deals

Takeda plans $10bn asset sale to reduce Shire burden

CFO hopeful of shareholder approval, despite opposition from founding family

With the disposal of noncore assets, Takeda will prioritize such core fields as vaccines.

TOKYO -- Takeda Pharmaceutical will consider selling off up to $10 billion in assets to slash the debt from its planned purchase of Irish peer Shire, Chief Financial Officer Costa Saroukos told Nikkei, as the management looks to soothe shareholder concern about the deal's financial impact on the company.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more